| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/16/1993 | US5262172 Compositions of gastric acid-resistant microspheres containing buffered bile acids |
| 11/16/1993 | US5262169 Tablets and granulates containing mesna as active substance |
| 11/16/1993 | US5262168 Liposomes with arachidonic acid metabolite, lipid and drying protectant formed by prelyophilization, lyophilization and reconstitution |
| 11/16/1993 | US5262167 Edible, non-baked low moisture cholestyramine composition |
| 11/16/1993 | US5262165 Transdermal nitroglycerin patch with penetration enhancers |
| 11/16/1993 | US5262164 Insertion into or around the tooth cavity the drug monolein mixed with vitamins, antiiinflammatory agents, antibiotics, peroxides, anesthetic agents and microbactericides |
| 11/16/1993 | US5262157 Method of preventing Pneumocystis carinii pneumonia using pentamidine in an aerosol form |
| 11/16/1993 | US5262155 Glycerol functional polysiloxanes |
| 11/16/1993 | US5262152 Amidrazones and derivatives thereof |
| 11/16/1993 | US5262150 Antifungus composition in dry spray form |
| 11/16/1993 | US5262149 Method of treating or preventing alopecia |
| 11/16/1993 | CA2096281A1 Octahydronaphthalene oxime derivatives for cholesterol biosynthesis inhibition, their preparation and use |
| 11/16/1993 | CA2068745A1 Treatment of cardiovascular disease associated with diabetes, uremia, gout and arthritis |
| 11/16/1993 | CA1324389C Process for preparing chf_ochfcf_ and chf_ochc1cf_ and novel intermediate compounds employed therein |
| 11/16/1993 | CA1324383C Process for the manufacture of novel substituted aminomethanediphosphonic acids |
| 11/16/1993 | CA1324382C Isoxazole-.beta.-carboline derivatives |
| 11/16/1993 | CA1324381C Aryl-substituted naphthyridine and pyridopyrazine derivatives |
| 11/16/1993 | CA1324380C Pyridazinone derivatives |
| 11/16/1993 | CA1324378C Perhydroazacycloalka [1,2-a] imidazole derivatives and use thereof as nootropic agents |
| 11/16/1993 | CA1324374C 17-halomethylene estratrienes |
| 11/15/1993 | CA2095968A1 Dithiolanylglycine-containing hiv protease inhibitors of the hydroxyethylene isostere type |
| 11/15/1993 | CA2095424A1 Microporous polysulfone support suitable for removal of low density lipoprotein-cholesterol |
| 11/14/1993 | CA2096067A1 Diazabicycloalkene derivatives |
| 11/13/1993 | CA2095802A1 Biphenylmethyl-substituted pyridones |
| 11/13/1993 | CA2095801A1 Sulfonylbenzyl-substituted benzo- and pyridopyridones |
| 11/13/1993 | CA2095006A1 Oxime derivatives |
| 11/13/1993 | CA2095005A1 Hydroxylamine derivatives |
| 11/11/1993 | WO1993023405A1 Use of tricyclic pyrimidine derivatives as anti-viral medicaments |
| 11/11/1993 | WO1993022685A1 Evaluative means for detecting inflammatory reactivity |
| 11/11/1993 | WO1993022681A1 NOVEL GABAa RECEPTOR SUBTYPES AND METHODS FOR SCREENING DRUG COMPOUNDS USING IMIDAZOQUINOXALINES AND PYRROLOPYRIMIDINES TO BIND TO GABAa RECEPTOR SUBTYPES |
| 11/11/1993 | WO1993022434A2 Targeted cleavage of rna using eukaryotic ribonuclease p and external guide sequence |
| 11/11/1993 | WO1993022431A1 Constitutive and inducible epidermal vector systems |
| 11/11/1993 | WO1993022430A1 Development of a vector to target gene expression to the epidermis of transgenic animals |
| 11/11/1993 | WO1993022410A1 Lanolin fatty acids, separation thereof, and cosmetic and external preparation |
| 11/11/1993 | WO1993022333A1 17α AND 17β-SUBSTITUTED ESTRA-1,3,5(10)-TRIENE-3-CARBOXYLIC ACID |
| 11/11/1993 | WO1993022328A1 Adenosine derivatives having a2 agonist activity |
| 11/11/1993 | WO1993022312A1 Deazaaminopterins for treatment of inflammation |
| 11/11/1993 | WO1993022310A1 (n-phthalimidoalkyl)piperidines for the treatment of psychoses |
| 11/11/1993 | WO1993022309A1 4-imidomethyl-1-[2'phenyl-2'oxoethyl-] piperidines as serotonin 5ht2-antagonists, their preparation and use in therapy |
| 11/11/1993 | WO1993022307A1 Avermectin difluoro derivatives |
| 11/11/1993 | WO1993022304A1 Phenylderivate as inhibitors of atp citrate lyase |
| 11/11/1993 | WO1993022303A1 1-piperazineacetic derivatives as fibrinogen receptor antagonists |
| 11/11/1993 | WO1993022302A1 N-aryloxy(thio)alkyl-azacycloalkanes useful as calcium channel antagonists |
| 11/11/1993 | WO1993022293A1 1-piperazino-1,2-dihydroindene derivatives |
| 11/11/1993 | WO1993022292A1 New quinazolines as inhibitors of hiv reverse transcriptase |
| 11/11/1993 | WO1993022288A1 Pleuromutilin derivatives |
| 11/11/1993 | WO1993022286A1 Novel tetracyclic compound |
| 11/11/1993 | WO1993022279A1 Diamine derivatives having selective affinity for sigma receptors |
| 11/11/1993 | WO1993022275A1 Substituted 1,1,2-triphenylbutenes and their use in the treatment and diagnosis of cancer |
| 11/11/1993 | WO1993022271A1 Monounsaturated fat as dietary supplement to minimize the effects of catabolic illness |
| 11/11/1993 | WO1993022267A1 Novel retinol derivatives and uses thereof |
| 11/11/1993 | WO1993022262A1 Novel bis-phenyl-hexenes |
| 11/11/1993 | WO1993021992A1 Laser treatment |
| 11/11/1993 | WO1993021959A1 Bystander effect tumoricidal therapy |
| 11/11/1993 | WO1993021954A1 Slip1/sulfated-glyco moiety interfering compositions and methods for inhibition of fertilization |
| 11/11/1993 | WO1993021948A1 Peptide-carbohydrate conjugates generating t-cell immunity |
| 11/11/1993 | WO1993021937A1 Non-bitter protein hydrolyzates |
| 11/11/1993 | WO1993021929A1 Phosphorothioate derivatives of cyclic amp analogues |
| 11/11/1993 | WO1993021927A1 Minimizing progestin associated breakthrough bleeding |
| 11/11/1993 | WO1993021926A1 Minimizing progestin associated breakthrough bleeding |
| 11/11/1993 | WO1993021925A1 Pharmaceutical mixture |
| 11/11/1993 | WO1993021924A1 Drug for increasing the level of testosterone in the body |
| 11/11/1993 | WO1993021923A1 Stable hydrated cephalosporin dry powder for oral suspension formulation |
| 11/11/1993 | WO1993021922A1 Antirheumatic |
| 11/11/1993 | WO1993021921A1 Anti-ischemic medicament |
| 11/11/1993 | WO1993021920A1 Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic |
| 11/11/1993 | WO1993021919A1 Hydroxypyridin-4-ones for treatment of parasitical infections |
| 11/11/1993 | WO1993021918A1 Fat emulsion containing fatty acid ester of rhizoxin |
| 11/11/1993 | WO1993021917A1 Dopamine and noradrenergic reuptake inhibitors in treatment of schizophrenia |
| 11/11/1993 | WO1993021916A1 Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration |
| 11/11/1993 | WO1993021915A1 Pharmaceutical compositions for inhibiting bone loss containing 3 and 4-substituted 2(5h)-furanones |
| 11/11/1993 | WO1993021914A1 Soluble analogs of probucol |
| 11/11/1993 | WO1993021913A1 Anti-obesity drugs |
| 11/11/1993 | WO1993021912A1 Use of an emulsion containing omega-3 fatty acids to produce a medicament to be parenterally administered for treating inflammatory diseases |
| 11/11/1993 | WO1993021910A1 Use of remacemide for the treatment of parkinson's disease |
| 11/11/1993 | WO1993021909A1 Improved delivery formulation for lipophilic drugs |
| 11/11/1993 | WO1993021907A1 Pharmaceutical preparation and process for its manufacture |
| 11/11/1993 | WO1993021904A1 Retinoic acid-containing compositions |
| 11/11/1993 | WO1993021899A1 Acne treating composition |
| 11/11/1993 | WO1993021894A2 Treatment of macular degeneration |
| 11/11/1993 | WO1993021783A1 Methods of treating obesity with purine related compounds |
| 11/11/1993 | WO1993021771A1 Compositions and methods for regulating il-6 production in vivo |
| 11/11/1993 | WO1993017691A3 Pharmaceutical compositions containing monosialoganglioside gm1 or a derivative thereof suitable for the treatment of parkinson's disease |
| 11/11/1993 | WO1993001169A3 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| 11/11/1993 | DE4214953A1 Arzneimittel zur Erhöhung des Testosteronspiegels Medicines to increase testosterone levels |
| 11/11/1993 | DE4214830A1 Neue Tricyclische Thiazolo- und Thiazino-Derivate und diese enthaltende Arzneimittel New Tricyclic thiazolo- and thiazino derivatives and pharmaceutical compositions containing them |
| 11/11/1993 | DE4214829A1 Verwendung von tricyclischen Pyrimidin-Derivaten als antivirale Arzneimittel Use of tricyclic pyrimidine derivatives as antiviral drugs |
| 11/11/1993 | CA2404943A1 Soluble analogs of probucol |
| 11/11/1993 | CA2135298A1 Novel retinol derivatives and uses thereof |
| 11/11/1993 | CA2134979A1 Acne treating composition |
| 11/11/1993 | CA2134772A1 Substituted 1 , 1, 2 - triphenylbutenes and their use in the treatment and diagnosis of cancer |
| 11/11/1993 | CA2134763A1 Bystander effect tumoricidal therapy |
| 11/11/1993 | CA2134675A1 Development of a vector to target gene expression to the epidermis of transcenic animals |
| 11/11/1993 | CA2134670A1 Constitutive and inducible epidermal vector systems |
| 11/11/1993 | CA2134658A1 Monounsaturated fat as dietary supplement to minimize the effects of catabolic illness |
| 11/11/1993 | CA2134657A1 Methods of treating obesity with purine related compounds |
| 11/11/1993 | CA2134467A1 Stable hydrated cephalosporin dry powder for oral suspension formulation |
| 11/11/1993 | CA2134231A1 17.alpha. and 17.alpha.-substituted estra-1,3,5(10)-triene-3-carboxylic acid |
| 11/11/1993 | CA2134228A1 Compositions and methods for regulating il-6 production in vivo |
| 11/11/1993 | CA2134227A1 Novel gabaa receptor subtypes and methods for screening drug compounds using imidazoquinoxalines and pyrrolopyrimidines to bind to gabaa receptor subtypes |